Phase 2 Study to Evaluate PVX-410 + Pembrolizumab + Chemotherapy for Metastatic, PD-L1+ Triple-Negative Breast Cancer

Clinical trial NCT04634747 · UNKNOWN

Trial details

NCT number: NCT04634747
Sponsor: OncoPep, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Triple-Negative Breast Carcinoma

Start date: 2022-04-30
Primary completion: 2023-04-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.